Context Therapeutics (NASDAQ:CNTX) PT Raised to $10.00 at Maxim Group tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Lake Street Capital assumed coverage on shares of Biodesix (NASDAQ:BDSX – Free Report) in a report issued on Friday, Marketbeat reports. The brokerage issued a buy rating and a $3.00 price target on the stock. Separately, Canaccord Genuity Group reaffirmed a buy rating and set a $3.50 target price on shares of Biodesix in a […]
Biodesix (NASDAQ:BDSX) Now Covered by Analysts at Lake Street Capital themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Codexis (NASDAQ:CDXS – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Benchmark in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $9.00 target price on the biotechnology company’s stock. Benchmark’s target price suggests a potential upside of 129.59% from the stock’s current […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 and traded as low as $5.28. Syros Pharmaceuticals shares last traded at $5.44, with a volume of 199,560 shares traded. Wall Street Analysts […]